NATCO Pharma Semaglutide gains 12% after CDSCO approval in India. Discover the impact on the market and future prospects.
Read MoreNATCO Pharma Semaglutide gains 12% after CDSCO approval in India. Discover the impact on the market and future prospects.
Read More
Azerbaijan Oncology Approval brings exciting news for Beta Drugs investors. Discover the latest updates and what it means for the…
Read More